Resources for journalists, editors, and media professionals covering healthcare innovation, hyperbaric medicine, and medical device technology.
After his previous article received attention, the International Business Times (IBTimes) invited Founder & CEO Diallo M. Watts, Sr. to write an opinion piece. This article is not about RxAir360 specifically — it focuses on a broader problem: geography and outdated delivery models continue to keep too many patients from receiving care that already exists and already works.
"We spend $5 trillion annually on healthcare, yet for too many patients, the greatest barrier to better care isn't science — it's geography."
RxAir360 Inc. has been featured in national media publications covering the company's mission to expand access to hyperbaric oxygen therapy. The Founder's story and the company's patented vertical monoplace chamber design have drawn attention from healthcare journalists and industry observers nationwide.
IBTimes covers the origin story behind RxAir360 and Founder Diallo M. Watts Sr.'s personal mission to bring hyperbaric oxygen therapy into physician offices across the country.
Read the ArticleWellness Voice features the RxAir360 story and the company's commitment to making HBOT accessible through its physician-office deployment model.
Read the ArticleMedia inquiries: media@rxair360inc.com
Stay updated with the latest interviews, news, and insights from RxAir360
Join Founder & CEO Diallo M. Watts, Sr. and Chief Sales Officer Tony Brown as they discuss: "Hyperbaric oxygen therapy shouldn't be limited to 1,300 facilities in America. Why closing this access gap matters — especially for the communities that need it most."
WLIT 106 FM • "The Mornin' Experience" with Marquis Lupton
A quick 2-page synopsis of The Hyperbaric Access Gap research brief, summarizing key findings for the DC, Maryland, and Virginia region.
Download PDFFirst in a 4-part series — A data-driven analysis of geographic disparities in hyperbaric oxygen therapy access across the DC, Maryland, and Virginia region.
Download PDFSubscribe to our media list to get the latest news, interview links, and announcements delivered directly to your inbox.
High-resolution images of the RxAir360 chamber and system components for media use.
RxAir360 Monoplace Chamber System
FDA Pending • Community-Ready Design
Request logos and brand assets for media use.
Primary Logo
Wordmark
All Assets
Use this version everywhere a short bio is needed.
Diallo M. Watts, Sr. is the Founder and CEO of RxAir360 Inc., a medical technology company focused on expanding access to hyperbaric oxygen therapy by bringing HBOT into physician practice environments. A trained electrical engineer with more than 25 years of experience in engineering, entrepreneurship, and executive leadership, he leads the company's regulatory, engineering, and commercialization strategy. Under his leadership, RxAir360 has raised close to $1M per year in its first four years of raising funds toward commercialization and is advancing a patented hyperbaric oxygen therapy system designed for integration within physician offices.
Media Contact Email
Phone
(240) 640-4560
March 2026: "The Mornin' Experience" - WLIT 106 FM (with Tony Brown, Chief Sales Officer)
Topic: Geographic Disparities in Access to Hyperbaric Oxygen Therapy
Education
B.S. Electrical Engineering, Morgan State University
Location
Bellaire, TX (Houston area)
For use in articles, press releases, and media coverage
RxAir360 Inc. is a pre-revenue medical technology company developing hyperbaric oxygen therapy (HBOT) systems for physician offices, pending FDA 510(k) clearance.
RxAir360 Inc. is a Bellaire, Texas (Houston area)-based medical technology company developing innovative hyperbaric oxygen therapy (HBOT) systems designed specifically for physician offices. Unlike traditional hyperbaric chambers requiring large hospital spaces, the RxAir360 vertical monoplace system is designed for physician office integration — with a compact footprint intended to fit within many standard exam rooms. The company has filed Form 211 for OTC market qualification and is advancing toward FDA 510(k) clearance. RxAir360 is backed by over 200 investors including physicians, self-directed IRA holders, and accredited individuals. The device is not yet cleared by the FDA and is not available for sale or clinical use.
For interview requests, image assets, executive bios, or additional background, please contact our media relations team.
Contact Media RelationsRxAir360 requests that any coverage of the company accurately reflect the pre-clearance status of the device and not represent it as commercially available. The RxAir360 chamber has not received FDA 510(k) clearance.
Company Name
RxAir360 Inc.
Founded
2022
Headquarters
Bellaire, Texas (Houston area)
Incorporation
Delaware Corporation
Stage
Pre-revenue medical technology company
Product
Vertically-oriented clinical monoplace hyperbaric oxygen therapy chamber designed for physician offices
Regulatory Status
FDA 510(k) submission in process
Patent
Issued U.S. patent covering the only monoplace HBOT system designed for standard physician exam rooms
Market Maker
Glendale Securities, Inc.
Transfer Agent
Dynamic Stock Transfer, Inc.
Securities Counsel
SD Mitchell & Associates, PLC
OTC Markets
Form 211 filed
For press inquiries, interview requests, or additional information
Press Contact - 480 Advisors
Response Time
We typically respond to media inquiries within 24-48 hours
Photography
High-resolution images available upon request
Interviews
CEO available for print, broadcast, and podcast interviews
Quotes & Attribution
Please contact us for approval before publishing quotes
Fact Verification
We're happy to verify facts and review technical details
